Baxter Healthcare Corporation recalls Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation
Recalled December 13, 2023 · FDA recall D-0146-2024 · Baxter Healthcare
Hazard
Failed pH Specifications · FDA Class II
Units
6,022,675 vials
Sold at
Nationwide in the USA
Description
Failed pH Specifications
Product
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25
Manufacturer(s)
Baxter Healthcare Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →